cjc/ipamorelin vs igf 1 lr3 looksmax IGF-1 peptide: complete guide to insulin-like growth factor for muscle growth cjc-1295 + ipamorelin + igf-1
Description
Clinical observations report that subcutaneous dosing 3060 minutes before bedtime shortens sleep latency and increases deepsleep proportion within 12 weeks, with optimal benefits after 68 weeks of therapy Peptide therapy improves sleep by restoring natural hormone production
It not only inhibits MAOB but also modulates glutamate release, significantly reducing the incidence of motor fluctuations [115, 116]
Similar to other peptides, it has to be injected subcutaneously and injection sites must be rotated to prevent lipodystrophy
Nature 502 , 327332 (2013)
